2014 annual financial data
Alnylam Pharmaceuticals 2014 Operating margin
Alnylam Pharmaceuticals 2014 operating margin with verified reported values.
Direct answer
Operating margin was -800.97%.
Operating income was -404,980,000 USD and net income was -360,395,000 USD.
Operating cash flow was -165,641,000 USD.
Get free Alnylam Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 50,561,000 USD
- Operating income
- -404,980,000 USD
- Net income
- -360,395,000 USD
- Operating cash flow
- -165,641,000 USD